Insider Trading History of Gardiner Nathaniel S.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Gardiner Nathaniel S. since 2015. This trader's CIK number is 1607643. At the time of last reporting, Gardiner Nathaniel S. was the Chief Legal Officer of Enanta Pharmaceuticals Inc. (stock ticker symbol ENTA). Also see all insider trading activities at Enanta Pharmaceuticals Inc.


Yearly summary of insider trading at Enanta Pharmaceuticals Inc (ENTA) by Gardiner Nathaniel S.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ENTA 0 $0 0 $0 5,187 $46,631
2023 ENTA 0 $0 2,412 $23,227 6,667 $200,010
2020 ENTA 0 $0 0 $0 16,833 $189,990
2019 ENTA 0 $0 3,270 $311,562 14,406 $456,226
2018 ENTA 0 $0 0 $0 7,800 $270,660
2016 ENTA 500 $12,222 0 $0 0 $0
2015 ENTA 1,400 $46,485 0 $0 0 $0


Insider trading of Enanta Pharmaceuticals Inc (ENTA) by Gardiner Nathaniel S.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-02-26 ENTA Option Ex 5,187 8.99 46,631
2023-12-05 ENTA Sale 2,412 9.63 23,227
2023-04-18 ENTA Option Ex 6,667 30.00 200,010
2020-12-15 ENTA Option Ex 5,250 .00 0
2020-12-03 ENTA Option Ex 1,667 30.00 50,010
2020-08-05 ENTA Option Ex 1,666 30.00 49,980
2020-03-12 ENTA Option Ex 3,000 30.00 90,000
2019-12-16 ENTA Option Ex 5,250 .00 0
2019-11-22 ENTA Option Ex 1,592 31.42 50,020
2019-09-27 ENTA Option Ex 5,000 30.00 150,000
2019-06-26 ENTA Option Ex 3,295 31.42 103,528
2019-03-06 ENTA Option Ex 2,519 33.06 83,278
2019-02-13 ENTA Sale 3,270 95.28 311,562
2019-01-22 ENTA Option Ex 2,000 34.70 69,400
2018-12-06 ENTA Option Ex 2,000 34.70 69,400
2018-10-01 ENTA Option Ex 1,500 34.70 52,050
2018-02-08 ENTA Option Ex 4,300 34.70 149,210
2016-05-11 ENTA Buy 500 24.45 12,222
2015-02-17 ENTA Buy 1,000 33.28 33,285
2015-02-13 ENTA Buy 400 33.00 13,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gardiner Nathaniel S. (Chief Legal Officer of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.